301 related articles for article (PubMed ID: 21923437)
1. Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.
Pinney MF; Rosenberg AF; Hampp C; Schain D; Akindipe O; Baz M
Pharmacotherapy; 2011 Jun; 31(6):537-45. PubMed ID: 21923437
[TBL] [Abstract][Full Text] [Related]
2. Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole.
Hayes D; Ball AM; Mansour HM; Martin CA; Flynn JD
Exp Clin Transplant; 2011 Dec; 9(6):399-404. PubMed ID: 22142048
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic antifungal agents used after lung transplantation.
Marino E; Gallagher JC
Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
[TBL] [Abstract][Full Text] [Related]
5. Antifungal prophylaxis in lung transplantation.
Avery RK
Semin Respir Crit Care Med; 2011 Dec; 32(6):717-26. PubMed ID: 22167399
[TBL] [Abstract][Full Text] [Related]
6. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients.
Silveira FP; Kwak EJ; Paterson DL; Pilewski JM; McCurry KR; Husain S
J Heart Lung Transplant; 2008 Aug; 27(8):850-5. PubMed ID: 18656797
[TBL] [Abstract][Full Text] [Related]
7. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal infections in renal transplant recipients: about 11 cases.
Trabelsi H; Néji S; Sellami H; Yaich S; Cheikhrouhou F; Guidara R; Charffedine K; Makni F; Hachicha J; Ayadi A
J Mycol Med; 2013 Dec; 23(4):255-60. PubMed ID: 24060353
[TBL] [Abstract][Full Text] [Related]
9. Aspergillus infections in lung transplant recipients: risk factors and outcome.
Solé A; Morant P; Salavert M; Pemán J; Morales P;
Clin Microbiol Infect; 2005 May; 11(5):359-65. PubMed ID: 15819861
[TBL] [Abstract][Full Text] [Related]
10. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients.
Helmi M; Love RB; Welter D; Cornwell RD; Meyer KC
Chest; 2003 Mar; 123(3):800-8. PubMed ID: 12628881
[TBL] [Abstract][Full Text] [Related]
11. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
[TBL] [Abstract][Full Text] [Related]
12. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
Koo S; Kubiak DW; Issa NC; Dietzek A; Boukedes S; Camp PC; Goldberg HJ; Baden LR; Fuhlbrigge AL; Marty FM
Transplantation; 2012 Aug; 94(3):281-6. PubMed ID: 22790447
[TBL] [Abstract][Full Text] [Related]
13. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.
Chong PP; Kennedy CC; Hathcock MA; Kremers WK; Razonable RR
Clin Transplant; 2015 Apr; 29(4):311-8. PubMed ID: 25604399
[TBL] [Abstract][Full Text] [Related]
15. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
16. Fungal infections in solid organ transplantation.
Silveira FP; Husain S
Med Mycol; 2007 Jun; 45(4):305-20. PubMed ID: 17510855
[TBL] [Abstract][Full Text] [Related]
17. Is universal antifungal prophylaxis mandatory in lung transplant patients?
Schaenman JM
Curr Opin Infect Dis; 2013 Aug; 26(4):317-25. PubMed ID: 23743815
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
19. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
Grow WB; Moreb JS; Roque D; Manion K; Leather H; Reddy V; Khan SA; Finiewicz KJ; Nguyen H; Clancy CJ; Mehta PS; Wingard JR
Bone Marrow Transplant; 2002 Jan; 29(1):15-9. PubMed ID: 11840139
[TBL] [Abstract][Full Text] [Related]
20. [Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants].
Quindós G
Rev Iberoam Micol; 2011; 28(3):110-9. PubMed ID: 21700230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
